Synthesis, anticonvulsant and antihypertensive activities of 8-substituted quinoline derivatives

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 10, 2004, Pages 1683-1687

  Muruganantham, Nithyanantham ^a   Sivakumar, Ramaiah ^a   Anbalagan, Navaneetharaman ^b   Gunasekaran, Vedachalam ^a   Leonard, Joseph Thomas ^a  

^a VELS INSTITUTE OF SCIENCE   (India)

^b C L BAID METHA COLLEGE OF PHARMACY   (India)

Author keywords

Anticonvulsant; Antihypertensive; Aryloxypropanolamine; Quinoline

Indexed keywords

19 [8 [3' (4 ETHYLPIPERAZINO) 2' HYDROXYPROPYLOXY]QUINOLINE]; 2 HYDROXYPROPYLOXYQUINOLINE; 8 (2' DIETHANOLAMINOETHANOXY)QUINOLINE; 8 (2' DIPHENYLAMINOETHANOXY)QUINOLINE; 8 (2' PHENYLAMINOETHANOXY)QUINOLINE; 8 (3' (4 ETHYLPIPERAZINO) 2' HYDROXYPROPYLOXY)QUINOLINE; 8 (3' METHYLAMINO 2' HYDROXYPROPYLOXY)QUINOLINE; 8 (9 3' DIETHYLAMINO 2' HYDROXYPROPLOXY)QUINOLINE; 8 [2' (2 AMINOPHENYLAMINO)ETHANOXY]QUINOLINE; 8 [2' (4 BROMOPHENYLAMINO)ETHANOXY]QUINOLINE; 8 [2' (4 ETHYLPIPERAZINYL)ETHANOXY]QUINOLINE; 8 [2' (4 HYDROXYPHENYLAMINO)ETHANOXY]QUINOLINE; 8 [2' (4 METHYLPIPERAZINYL)ETHANOXY]QUINOLINE; 8 [2' (4 NITROPHENYLAMINO)ETHANOXY]QUINOLINE; 8 [3' (4 HYDROXYPHENYLAMINO) 2' HYDROXYPROPYLOXY]QUINOLINE; 8 [3' DIPHENYLAMINO 2' HYDDROXYPROPYLOXY]QUINOLINE; [8 (2' PIPERAZINO ETHANOXY)QUINOLINE]; [8 (3' (4 PHENYLPIPERAZINO) 2' HYDROXYPROPYLOXYQUINOLINE]; [8 (3' IMIDAZOLO) 2' HYDROXYPROPYLOXYQUINOLINE]; [8 (3' PIPERAZINO) 2' HYDROXYPROPYLOXYQUINOLINE]; [8 [3' (4 PHENYLPIPERAZINO) 2' HYDROXYPROPYLOXY]QUINOLINE]; ADRENALIN; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ARYLOXYPROPANOLAMINE; ETHANE; PROPRANOLOL DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRESSOR RESPONSE; RAT; ROTAROD TEST; ANIMAL; INFRARED SPECTROPHOTOMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; QUINOLINES; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 21644444324     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1683     Document Type: Article

References (24)

1. Chen Y. L., Fang K. C., Shen J. Y., Hsu S. L., Tzeng C. C., J. Med. Chem., 44, 2374-2386 (2001).
2. Tajana A., Leonardi A., Cappalletti R., Nardi D., Massarini E., Degan L., Boll. Chim. Farm., 112, 767-769 (1973).
3. Papageorgion C., Matt A. V., Joergensen J., Anderson E., Wagner K., Beerli C., Than T., Borex X., Florineth A., Rihs S., Schreier M. H., Weckbecker G., Hausser C., J. Med. Chem., 44, 1986-1995 (2001).
4. Shinkai H., Ito T., Ida T., Kitao Y., Yamadu H., Uchida I., J. Med. Chem., 43, 4667-4672 (2000).
5. Ferline M. G., Chiarelotto G., Antonucci F., Caparrotta L., Froldi G., Eur. J. Med. Chem., 37, 427-431 (2002).
6. Kaschula C. H., Egan T. J., Hunter R., Basilico N., Parapini S., Taramelli D., Pasini E., Monti D., J. Med. Chem., 45, 3531-3539 (2002).
7. Kociubinska A., Gubernator J., Godlewska J., Stasiuk M., Kozubek A., Peczynska-Czoch W., Opolski A., Kaczmarek L., Cell Mol. Biol. Lett., 7, 289 (2002).
8. Joseph B., Darro F., Behard A., Lesur B., Collignon F., Decaestecker C., Frydman A., Guillaumet G., Kiss R., J. Med. Chem., 45, 2543-2555 (2002).
9. Billah M. H., Cooper N., Minnicozzi M., Warneck J., Wang P., Hey J. A., Kreutner W., Rizzo C. A., Smith S. R., Young S., Chapman R. W., Dyke H., Shih N. Y., Piwinski J. J., Cuss F. M., Mountana J., Ganguly A. K., Egan R. W., J. Pharmacol. Exp. Ther., 302, 127-137 (2002).
10. Nathanson A. J., Hunnicutt E. J., J. Pharm. Pharmacol., 40, 803-805 (1998).
11. Samant S. D., Gupte S. M., Kulkarni R. A., Indian J. Chem., 19B, 524-525 (1980).
12. Agarwal S. K., Saxena A. K., Jain P. C., Anand N., Sur R. N., Srimal R. C., Dhawan B. N., Indian J. Chem., 30B, 413-416 (1991).
13. Ahmed B., Siddiqui A. A., Agarwal M., Indian J. Pharmacol., 31, 33-35 (1999).
14. Leonard J. T., Anbalagan N., Kumar S. S., Kishore G. S., Sridhar S. K., Biol. Pharm. Bull., 25, 215-217 (2002).
15. Leonard J. T., Sivakumar R., Anbalagan N., Kumar S. S., Sridhar S. K., Boll. Chim. Farm., 141, 357-360 (2002).
16. Leonard J. T., Gangadhar R., Gnanasam S. K., Ramachandran S., Saravanan M., Sridhar S. K., Biol. Pharm. Bull., 25, 798-802 (2002).
17. Sivakumar R., Gnanasam S. K., Ramachandran S., Leonard J. T., Eur. J. Med. Chem., 37, 793-801 (2002).
18. Narendar P., Parthiban J., Anbalagan N., Gunasekaran V., Leonard J. T., Biol. Pharm. Bull., 26, 182-187 (2003).
19. Ravlee I., Sivakumar R., Muruganantham N., Anbalagan N., Gunasekaran V., Leonard J. T., Chem. Pharm. Bull., 51, 162-170 (2003).
20. Sivakumar R., Anbalagan N., Gunasekaran V., Leonard J. T., Biol. Pharm. Bull., 26, 1407-1411 (2003).
21. Krall R. L., Penry J. K., White B. G., Kupferberg H. J., Swinyard E. A., Epilepsia, 19, 409-428 (1978).
22. Porter R. J., Cereghino J. J., Gladding G. D., Hessie B. J., Kupferberg H. J., Scoville B., White B. G., Cleveland Clin. Q., 51, 293-305 (1984).
23. Kalman H. O., Timmermans P. B. M. W. M., VanZwieten P. A., J. Pharmacol. Exp. Ther., 222, 227-231 (1982).
24. Konkar A. A., Zhu Z., Granneman J. G., J. Pharmacol. Exp. Ther., 294, 923-932 (2000).